Europe - Euronext Milan - BIT:1BDX - US0758871091 - Common Stock
The current stock price of 1BDX.MI is 156.7 EUR.
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| 2M6.DE | MEDTRONIC PLC | 17.36 | 106.36B | ||
| SHL.DE | SIEMENS HEALTHINEERS AG | 18.62 | 50.20B | ||
| PHI1.DE | KONINKLIJKE PHILIPS NV | 15.41 | 21.95B | ||
| PHIA.AS | KONINKLIJKE PHILIPS NV | 15.36 | 21.90B | ||
| BIM.PA | BIOMERIEUX | 28.5 | 13.02B | ||
| OBCK.DE | OTTOBOCK SE & CO KGAA | 137.87 | 4.15B | ||
| DIA.MI | DIASORIN SPA | 20.13 | 3.73B | ||
| AFX.DE | CARL ZEISS MEDITEC AG - BR | 25.03 | 3.60B | ||
| DRW3.DE | DRAEGERWERK AG - PREF | 10.6 | 1.28B | ||
| ELN.MI | EL.EN. SPA | 21.7 | 1.12B | ||
| DRW8.DE | DRAEGERWERK AG | 8.84 | 1.07B | ||
| EUZ.DE | ECKERT & ZIEGLER SE | 23.03 | 950.89M |
Becton, Dickinson & Co. is a global medical technology company, which engages in the development, manufacture, and sale of medical supplies, devices, laboratory equipment, and diagnostic products. The company is headquartered in Franklin Lakes, New Jersey and currently employs 74,000 full-time employees. The firm is engaged in the development, manufacture and sale of a broad range of medical supplies, devices, laboratory equipment and diagnostic products used by healthcare institutions, physicians, life science researchers, clinical laboratories, and more. Its BD Medical segment produces an array of medical technologies and devices that are used to help improve healthcare delivery in a range of settings. The BD Medical segment consists of various business units, including medication delivery solutions, medication management solutions, advanced monitoring, and pharmaceutical systems. Its BD Life Sciences segment provides products for the collection and transport of diagnostics specimens, and instruments and reagent systems to detect a range of infectious diseases, healthcare-associated infections and cancers. Its BD Interventional segment provides vascular, urology, oncology and surgical specialty products.
BECTON DICKINSON AND CO
One Becton Drive
Franklin Lakes NEW JERSEY US
Employees: 74000
Phone: 12018476800
Becton, Dickinson & Co. is a global medical technology company, which engages in the development, manufacture, and sale of medical supplies, devices, laboratory equipment, and diagnostic products. The company is headquartered in Franklin Lakes, New Jersey and currently employs 74,000 full-time employees. The firm is engaged in the development, manufacture and sale of a broad range of medical supplies, devices, laboratory equipment and diagnostic products used by healthcare institutions, physicians, life science researchers, clinical laboratories, and more. Its BD Medical segment produces an array of medical technologies and devices that are used to help improve healthcare delivery in a range of settings. The BD Medical segment consists of various business units, including medication delivery solutions, medication management solutions, advanced monitoring, and pharmaceutical systems. Its BD Life Sciences segment provides products for the collection and transport of diagnostics specimens, and instruments and reagent systems to detect a range of infectious diseases, healthcare-associated infections and cancers. Its BD Interventional segment provides vascular, urology, oncology and surgical specialty products.
The current stock price of 1BDX.MI is 156.7 EUR. The price decreased by -4.89% in the last trading session.
BECTON DICKINSON AND CO (1BDX.MI) has a dividend yield of 2.37%. The yearly dividend amount is currently 3.28.
1BDX.MI has a ChartMill Technical rating of 2 out of 10 and a ChartMill Fundamental rating of 5 out of 10.
19 analysts have analysed 1BDX.MI and the average price target is 190.9 EUR. This implies a price increase of 21.83% is expected in the next year compared to the current price of 156.7.
This depends on your investment goals. Check the Technical and Fundamental Analysis tabs for insights on 1BDX.MI.
BECTON DICKINSON AND CO (1BDX.MI) has a market capitalization of 44.91B EUR. This makes 1BDX.MI a Large Cap stock.
ChartMill assigns a technical rating of 2 / 10 to 1BDX.MI.
ChartMill assigns a fundamental rating of 5 / 10 to 1BDX.MI. While 1BDX.MI is still in line with the averages on profitability rating, there are concerns on its financial health.
Over the last trailing twelve months 1BDX.MI reported a non-GAAP Earnings per Share(EPS) of 12.47. The EPS increased by 9.57% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 7.68% | ||
| ROA | 3.03% | ||
| ROE | 6.61% | ||
| Debt/Equity | 0.69 |
19 analysts have analysed 1BDX.MI and the average price target is 190.9 EUR. This implies a price increase of 21.83% is expected in the next year compared to the current price of 156.7.
For the next year, analysts expect an EPS growth of 3.94% and a revenue growth 4.3% for 1BDX.MI